ADVFN Logo ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Dati di Mercato
Notizie
Utensili
Mercato
Scoprire

Caratteristiche principali

Follow Feed

Connettiti con trader e investitori nella nostra comunità Follow Feed.

Flusso di Opzioni

Esplora i dati completi sulle opzioni e utilizza filtri avanzati con Options Flow.

Monitor

Organizza e monitora la tua watchlist di azioni e attività con Monitor.
Accedi/Registrati Premium IconPremium Help Menu
Ftse Mib
39.183,45
-1,33%
DAX
22.970,99
-1,42%
S&P 500
5.701,47
0,46%
NASDAQ
17.883,88
0,75%
Bitcoin
86.072,69
-0,94%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati
  1. Home
  2. Investire
  3. Azioni
  4. U.S.A.
  5. NASDAQ
  6. Sarepta Therapeutics Inc New (SRPT)

  7. Sarepta Therapeutics Inc New (SRPT) Notizie

SRPT

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics Inc New
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRPT
DataOraFonteTitoloSimboloCompagnia
14/03/202501:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
12/03/202522:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
03/03/202522:01Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SRPTSarepta Therapeutics Inc New
28/02/202522:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SRPTSarepta Therapeutics Inc New
28/02/202515:00Business WireSarepta Therapeutics Announces Call for Applications for the 8th Annual Route 79, The Duchenne Scholarship ProgramNASDAQ:SRPTSarepta Therapeutics Inc New
26/02/202522:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRPTSarepta Therapeutics Inc New
26/02/202522:05Business WireSarepta Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:SRPTSarepta Therapeutics Inc New
14/02/202523:23Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:SRPTSarepta Therapeutics Inc New
14/02/202519:32Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SRPTSarepta Therapeutics Inc New
14/02/202514:30Business WireSarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit FacilityNASDAQ:SRPTSarepta Therapeutics Inc New
12/02/202514:30Business WireSarepta Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
27/01/202507:00Business WireSarepta Therapeutics Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following Treatment with ELEVIDYSNASDAQ:SRPTSarepta Therapeutics Inc New
13/01/202518:25Business WireSarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2024 Net Product RevenueNASDAQ:SRPTSarepta Therapeutics Inc New
06/01/202514:30Business WireSarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SRPTSarepta Therapeutics Inc New
31/12/202422:10Business WireSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRPTSarepta Therapeutics Inc New
18/12/202414:30Business WireSarepta Therapeutics Completes Enrollment in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4NASDAQ:SRPTSarepta Therapeutics Inc New
30/11/202402:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
26/11/202413:00Business WireSarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA ProgramsNASDAQ:SRPTSarepta Therapeutics Inc New
14/11/202415:40Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SRPTSarepta Therapeutics Inc New
06/11/202422:05Business WireSarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:SRPTSarepta Therapeutics Inc New
06/11/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRPTSarepta Therapeutics Inc New
23/10/202414:30Business WireSarepta Therapeutics to Announce Third Quarter 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
26/09/202414:30Business WireSarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society CongressNASDAQ:SRPTSarepta Therapeutics Inc New
16/09/202414:30Business WireSarepta Therapeutics Appoints Deirdre Connelly to its Board of DirectorsNASDAQ:SRPTSarepta Therapeutics Inc New
05/09/202415:00Business WireSarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic YearNASDAQ:SRPTSarepta Therapeutics Inc New
30/08/202414:30Business WireSarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:SRPTSarepta Therapeutics Inc New
08/08/202411:53IH Market NewsBumble Plunges 36% on Weak Revenue; Warner Bros. Reports Significant Loss; Digital Turbine Surges 18%, and More in EarningsNASDAQ:SRPTSarepta Therapeutics Inc New
07/08/202422:50Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SRPTSarepta Therapeutics Inc New
07/08/202422:05Business WireSarepta Therapeutics Announces Second Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:SRPTSarepta Therapeutics Inc New
07/08/202411:49IH Market NewsUS Index Futures Rise Amid Earnings Season Optimism, Oil Prices ReboundNASDAQ:SRPTSarepta Therapeutics Inc New
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRPT

La tua Cronologia

NASDAQI
SX10PI
OMX Stockholm Technology...
BOV
EVEN3Q
EVEN ON
BOV
N1IS34
Nisource Inc. (Holding C...
BOV
RAIZ4T
Raizen S.A
BOV
EQPA7T
EQTL PARA
BOV
S1LG34Q
SL Green Realty
BOV
RZAT12
Riza Arctium Real Estate...
COIN
LATINOUSD
Latino Token
COIN
CHEETHUSD
Cheeth
BOV
BGLC39
BlackRock Institutional ...
BOV
S2HO34Q
Shopify
BOV
BEMV39
BlackRock Institutional ...
KUCN
H2OUSDT
H2O DAO
BOV
ITUB3M
ITAU UNIBANCO ON
BOV
WPLZ11
Fundo Invest Imobiliario...
BOV
K1RC34M
Kroger
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Italia
Azienda
Attività
Popular
Ottieni l'app
App Store
Google Play

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

© 2025 ADVFN PLC - Tutti i diritti riservati

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci